Clinical Trial Update: A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) [Phase 3]

View source ↗

Summary

Phase III study of JR-131 in renal anemia patients with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Renal Anemia

Drugs mentioned

• JR-131

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Anemia | Phase 3 | Status: COMPLETED